These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 30878630

  • 1. Evaluation of the ratio of the estimated area under the concentration-time curve to minimum inhibitory concentration (estimated AUIC) as a predictor of the outcome for tigecycline treatment for pneumonia due to multidrug-resistant bacteria in an intensive care unit.
    Xu Y, Jin L, Liu N, Luo X, Dong D, Tang J, Wang Y, You Y, Liu Y, Chen M, Yu Z, Hao Y, Gu Q.
    Int J Infect Dis; 2019 May; 82():79-85. PubMed ID: 30878630
    [Abstract] [Full Text] [Related]

  • 2. In nosocomial pneumonia, optimizing antibiotics other than aminoglycosides is a more important determinant of successful clinical outcome, and a better means of avoiding resistance.
    Schentag JJ, Birmingham MC, Paladino JA, Carr JR, Hyatt JM, Forrest A, Zimmer GS, Adelman MH, Cumbo TJ.
    Semin Respir Infect; 1997 Dec; 12(4):278-93. PubMed ID: 9436955
    [Abstract] [Full Text] [Related]

  • 3. Antimicrobial action and pharmacokinetics/pharmacodynamics: the use of AUIC to improve efficacy and avoid resistance.
    Schentag JJ.
    J Chemother; 1999 Dec; 11(6):426-39. PubMed ID: 10678784
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T>MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections.
    McKinnon PS, Paladino JA, Schentag JJ.
    Int J Antimicrob Agents; 2008 Apr; 31(4):345-51. PubMed ID: 18313273
    [Abstract] [Full Text] [Related]

  • 5. Monte Carlo simulation evaluation of tigecycline dosing for bacteria with raised minimum inhibitory concentrations in non-critically ill adults.
    Kispal B, Walker SAN.
    Eur J Clin Pharmacol; 2021 Feb; 77(2):197-205. PubMed ID: 32975650
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Mathematical examination of dual individualization principles (II): The rate of bacterial eradication at the same area under the inhibitory curve is more rapid for ciprofloxacin than for cefmenoxime.
    Goss TF, Forrest A, Nix DE, Ballow CH, Birmingham MC, Cumbo TJ, Schentag JJ.
    Ann Pharmacother; 1994 Feb; 28(7-8):863-8. PubMed ID: 7949501
    [Abstract] [Full Text] [Related]

  • 8. Pharmacological and patient-specific response determinants in patients with hospital-acquired pneumonia treated with tigecycline.
    Bhavnani SM, Rubino CM, Hammel JP, Forrest A, Dartois N, Cooper CA, Korth-Bradley J, Ambrose PG.
    Antimicrob Agents Chemother; 2012 Feb; 56(2):1065-72. PubMed ID: 22143524
    [Abstract] [Full Text] [Related]

  • 9. Comparable Efficacy of Tigecycline versus Colistin Therapy for Multidrug-Resistant and Extensively Drug-Resistant Acinetobacter baumannii Pneumonia in Critically Ill Patients.
    Kim WY, Moon JY, Huh JW, Choi SH, Lim CM, Koh Y, Chong YP, Hong SB.
    PLoS One; 2016 Feb; 11(3):e0150642. PubMed ID: 26934182
    [Abstract] [Full Text] [Related]

  • 10. [Study on the optimization of administration regimen of vancomycin in critical patients].
    Shi Y, He J, Mao E, Bian X, Zhou J, Chen E.
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Feb; 32(2):140-144. PubMed ID: 32274995
    [Abstract] [Full Text] [Related]

  • 11. Clinical efficacy and safety of tigecycline based on therapeutic drug monitoring for carbapenem-resistant Gram-negative bacterium pneumonia in intensive care units.
    Bai XR, Wang ZZ, Li WC, Wang YG, Lou R, Qu X, Fan L, Zhang W, Wu YC, Yan SY, Zhang L.
    BMC Infect Dis; 2023 Nov 27; 23(1):830. PubMed ID: 38012576
    [Abstract] [Full Text] [Related]

  • 12. Relationship of minimal inhibitory concentration and bactericidal activity to efficacy of antibiotics for treatment of ventilator-associated pneumonia.
    Kiem S, Schentag JJ.
    Semin Respir Crit Care Med; 2006 Feb 27; 27(1):51-67. PubMed ID: 16508882
    [Abstract] [Full Text] [Related]

  • 13. Impact of amikacin pharmacokinetic/pharmacodynamic index on treatment response in critically ill patients.
    Ruiz J, Ramirez P, Company MJ, Gordon M, Villarreal E, Concha P, Aroca M, Frasquet J, Remedios-Marqués M, Castellanos-Ortega Á.
    J Glob Antimicrob Resist; 2018 Mar 27; 12():90-95. PubMed ID: 29017888
    [Abstract] [Full Text] [Related]

  • 14. Clinical use of ceftriaxone: a pharmacokinetic-pharmacodynamic perspective on the impact of minimum inhibitory concentration and serum protein binding.
    Perry TR, Schentag JJ.
    Clin Pharmacokinet; 2001 Mar 27; 40(9):685-94. PubMed ID: 11605716
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Tigecycline Therapy for Nosocomial Pneumonia due to Carbapenem-Resistant Gram-Negative Bacteria in Critically Ill Patients Who Received Inappropriate Initial Antibiotic Treatment: A Retrospective Case Study.
    Wu X, Zhu Y, Chen Q, Gong L, Lin J, Lv D, Feng J.
    Biomed Res Int; 2016 Mar 27; 2016():8395268. PubMed ID: 28044137
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of low-dose colistin in the treatment for infections caused by multidrug-resistant gram-negative bacteria.
    Zaidi ST, Al Omran S, Al Aithan AS, Al Sultan M.
    J Clin Pharm Ther; 2014 Jun 27; 39(3):272-6. PubMed ID: 24593154
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetic/pharmacodynamic analysis of high-dose tigecycline, by Monte Carlo simulation, in plasma and sputum of patients with hospital-acquired pneumonia.
    Qin X, Kong L, Wu C, Zhang X, Xie M, Wu X.
    J Clin Pharm Ther; 2022 Dec 27; 47(12):2312-2319. PubMed ID: 36479719
    [Abstract] [Full Text] [Related]

  • 19. Reappraisal of Contemporary Pharmacokinetic and Pharmacodynamic Principles for Informing Aminoglycoside Dosing.
    Bland CM, Pai MP, Lodise TP.
    Pharmacotherapy; 2018 Dec 27; 38(12):1229-1238. PubMed ID: 30403305
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.